Mirena (Levonorgestrel)

Levonorgestrel, the active ingredient in Mirena, is a progestin presented as a 52 mg intrauterine system for intrauterine use. It continuously releases levonorgestrel to suppress ovulation, thicken cervical mucus and induce endometrial atrophy, providing effective contraception and reducing heavy menstrual bleeding in women of reproductive age.

GNH USA supplies Mirena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to European Union medical device regulations and prescription‑only status to ensure quality and regulatory conformity across global markets.

Levonorgestrel in Mirena acts within the hormonal contraceptive and menstrual‑management pathways. - Contraception: provides highly effective, long‑term birth control for up to five years. - Heavy menstrual bleeding: reduces menstrual blood loss and can improve anemia associated with excessive bleeding. - Endometrial hyperplasia (benign): induces regression of non‑cancerous endometrial overgrowth through local progestogenic effect.

Levonorgestrel delivered by Mirena may be associated with a range of adverse reactions.

Common Side Effects: - Irregular vaginal bleeding or spotting. - Amenorrhea after several months of use. - Pelvic or uterine cramping after insertion.

Serious or Rare Side Effects: - Uterine perforation during insertion. - Device expulsion or displacement. - Pelvic inflammatory disease or infection.

Mirena requires careful patient assessment and follow‑up. - Contraindicated in pregnancy: product must not be used in women who are pregnant. - Screen for uterine abnormalities: perform ultrasound or hysteroscopy before insertion. - Risk of infection: insert under aseptic conditions and monitor for signs of pelvic infection. - Smoking in women over 35: advise cessation as smoking increases thrombotic risk. - Follow‑up examinations: schedule regular checks to confirm correct device position. - Store at room temperature: keep in original packaging, protect from moisture and extreme heat.

Levonorgestrel may interact with other medicines that affect hormone metabolism.

Major Interactions (Avoid): - Rifampin and other enzyme inducers: may reduce levonorgestrel efficacy. - Anticonvulsants (phenytoin, carbamazepine, phenobarbital): may lower hormone levels. - Antifungal ketoconazole: can increase levonorgestrel concentrations, raising risk of side effects.

Moderate Interactions (Monitor Closely): - St. John’s wort: may decrease hormonal effectiveness. - Certain antibiotics (e.g., tetracycline): generally minimal effect but monitor bleeding patterns. - Hormonal therapies (combined oral contraceptives): may alter bleeding profile.